vs
Side-by-side financial comparison of Andersons, Inc. (ANDE) and STAG Industrial, Inc. (STAG). Click either name above to swap in a different company.
Andersons, Inc. is the larger business by last-quarter revenue ($329.5M vs $224.2M, roughly 1.5× STAG Industrial, Inc.). STAG Industrial, Inc. runs the higher net margin — 27.6% vs 20.5%, a 7.2% gap on every dollar of revenue. On growth, STAG Industrial, Inc. posted the faster year-over-year revenue change (9.1% vs -2.4%). Over the past eight quarters, STAG Industrial, Inc.'s revenue compounded faster (8.7% CAGR vs -1.8%).
The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.
Stag Arms is a firearms manufacturer founded in May 2003 and located in Cheyenne, Wyoming. Stag Arms is a manufacturer of the AR-15 type rifle, marketed as Stag-15 rifles. Stag advertises that all their weapons and accessories are made in the United States. They are best known for their left-handed AR-15 rifles, which use a mirror imaged upper receiver and have the ejection port reversed for left-handed shooters and the safety selector control on the right side of the lower receiver.
ANDE vs STAG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $329.5M | $224.2M |
| Net Profit | $67.4M | $62.0M |
| Gross Margin | 70.3% | — |
| Operating Margin | 26.6% | — |
| Net Margin | 20.5% | 27.6% |
| Revenue YoY | -2.4% | 9.1% |
| Net Profit YoY | 49.6% | — |
| EPS (diluted) | — | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $224.2M | ||
| Q4 25 | $329.5M | $220.9M | ||
| Q3 25 | $295.8M | $211.1M | ||
| Q2 25 | $535.0M | $207.6M | ||
| Q1 25 | $370.8M | $205.6M | ||
| Q4 24 | $337.5M | $199.3M | ||
| Q3 24 | $231.9M | $190.7M | ||
| Q2 24 | $492.5M | $189.8M |
| Q1 26 | — | $62.0M | ||
| Q4 25 | $67.4M | $83.5M | ||
| Q3 25 | $20.1M | $48.6M | ||
| Q2 25 | $7.9M | $50.0M | ||
| Q1 25 | $284.0K | $91.4M | ||
| Q4 24 | $45.1M | $51.0M | ||
| Q3 24 | $27.4M | $41.9M | ||
| Q2 24 | $36.0M | $59.8M |
| Q1 26 | — | — | ||
| Q4 25 | 70.3% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 29.6% | — | ||
| Q1 25 | 41.2% | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | 76.4% | — | ||
| Q2 24 | 35.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 26.6% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 26.8% | — | ||
| Q2 24 | 11.6% | — |
| Q1 26 | — | 27.6% | ||
| Q4 25 | 20.5% | 37.8% | ||
| Q3 25 | 6.8% | 23.0% | ||
| Q2 25 | 1.5% | 24.1% | ||
| Q1 25 | 0.1% | 44.5% | ||
| Q4 24 | 13.4% | 25.6% | ||
| Q3 24 | 11.8% | 21.9% | ||
| Q2 24 | 7.3% | 31.5% |
| Q1 26 | — | $0.32 | ||
| Q4 25 | — | — | ||
| Q3 25 | $0.59 | — | ||
| Q2 25 | $0.23 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | $1.31 | — | ||
| Q3 24 | $0.80 | — | ||
| Q2 24 | $1.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.3M | $8.9M |
| Total DebtLower is stronger | $560.0M | — |
| Stockholders' EquityBook value | $1.2B | $3.6B |
| Total Assets | $3.7B | $7.2B |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $8.9M | ||
| Q4 25 | $98.3M | $14.9M | ||
| Q3 25 | — | $17.3M | ||
| Q2 25 | — | $15.4M | ||
| Q1 25 | — | $9.3M | ||
| Q4 24 | $561.8M | $36.3M | ||
| Q3 24 | — | $70.0M | ||
| Q2 24 | — | $33.3M |
| Q1 26 | — | — | ||
| Q4 25 | $560.0M | $3.3B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | — | $3.0B | ||
| Q1 25 | — | $3.0B | ||
| Q4 24 | $608.2M | $3.0B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | — | $2.8B |
| Q1 26 | — | $3.6B | ||
| Q4 25 | $1.2B | $3.6B | ||
| Q3 25 | $1.2B | $3.4B | ||
| Q2 25 | $1.4B | $3.4B | ||
| Q1 25 | $1.4B | $3.5B | ||
| Q4 24 | $1.4B | $3.5B | ||
| Q3 24 | $1.3B | $3.3B | ||
| Q2 24 | $1.3B | $3.3B |
| Q1 26 | — | $7.2B | ||
| Q4 25 | $3.7B | $7.2B | ||
| Q3 25 | $3.3B | $6.9B | ||
| Q2 25 | $3.4B | $6.8B | ||
| Q1 25 | $3.8B | $6.8B | ||
| Q4 24 | $4.1B | $6.8B | ||
| Q3 24 | $3.4B | $6.6B | ||
| Q2 24 | $3.3B | $6.4B |
| Q1 26 | — | — | ||
| Q4 25 | 0.45× | 0.91× | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.88× | ||
| Q1 25 | — | 0.87× | ||
| Q4 24 | 0.45× | 0.88× | ||
| Q3 24 | — | 0.89× | ||
| Q2 24 | — | 0.84× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.2M | — |
| Free Cash FlowOCF − Capex | $-77.1M | — |
| FCF MarginFCF / Revenue | -23.4% | — |
| Capex IntensityCapex / Revenue | 21.5% | 3.9% |
| Cash ConversionOCF / Net Profit | -0.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-56.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-6.2M | $104.5M | ||
| Q3 25 | $233.9M | $143.5M | ||
| Q2 25 | $299.3M | $111.9M | ||
| Q1 25 | $-350.0M | $103.5M | ||
| Q4 24 | $268.8M | $104.9M | ||
| Q3 24 | $-2.1M | $128.0M | ||
| Q2 24 | $304.4M | $122.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-77.1M | $43.8M | ||
| Q3 25 | $167.0M | $95.5M | ||
| Q2 25 | $250.5M | $62.3M | ||
| Q1 25 | $-396.6M | $57.2M | ||
| Q4 24 | $212.9M | $37.6M | ||
| Q3 24 | $-40.0M | $86.7M | ||
| Q2 24 | $275.8M | $105.0M |
| Q1 26 | — | — | ||
| Q4 25 | -23.4% | 19.8% | ||
| Q3 25 | 56.5% | 45.2% | ||
| Q2 25 | 46.8% | 30.0% | ||
| Q1 25 | -106.9% | 27.8% | ||
| Q4 24 | 63.1% | 18.8% | ||
| Q3 24 | -17.2% | 45.5% | ||
| Q2 24 | 56.0% | 55.3% |
| Q1 26 | — | 3.9% | ||
| Q4 25 | 21.5% | 27.4% | ||
| Q3 25 | 22.6% | 22.7% | ||
| Q2 25 | 9.1% | 23.9% | ||
| Q1 25 | 12.6% | 22.5% | ||
| Q4 24 | 16.6% | 33.8% | ||
| Q3 24 | 16.3% | 21.6% | ||
| Q2 24 | 5.8% | 9.1% |
| Q1 26 | — | — | ||
| Q4 25 | -0.09× | 1.25× | ||
| Q3 25 | 11.61× | 2.95× | ||
| Q2 25 | 38.10× | 2.24× | ||
| Q1 25 | -1232.46× | 1.13× | ||
| Q4 24 | 5.96× | 2.06× | ||
| Q3 24 | -0.08× | 3.06× | ||
| Q2 24 | 8.46× | 2.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
STAG
Segment breakdown not available.
